Cot-IN-5
Cot-IN-5 (compound 1) is a potent ATP-competitive inhibitor of cancer osaka thyroid (COT). Cot-IN-5 can block COT kinase autophosphorylation.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1798303-75-9
- Fòrmula: C18H14N2O2
- Peso molecular:290.32
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas MAP3K
More
Actividad biológica
Descripciòn
IC50 & Target
[1]|
MAP3K8/COT/Tpl2 |
Chemical Information
-
No. CAS 1798303-75-9
-
Peso molecular 290.32
-
Fòrmula C18H14N2O2
-
SMILES
OC(/C=C/C1=CC(C2=CC3=C(C=CC=C3)C=C2)=CN=C1N)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)